Supreme Court sides with Hikma in 'skinny label' case

June 4, 2026 11:04 AM EDT PharmaLaw Supreme Court sides with Hik­ma in 'skin­ny la­bel' case Nicole DeFeudis Senior Reporter The Supreme Court has unan­i­mous­ly sided with Hik­ma Phar­ma­ceu­ti­cals and its “skin­ny la­bel” ver­sion of a pre­scrip­tion-strength fish oil pill in a case that was … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER